Activation of receptor-associated tyrosine kinase JAK2 by prolactin. H Rui, RA Kirken, WL Farrar Journal of Biological Chemistry 269 (7), 5364-5368, 1994 | 417 | 1994 |
Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer D Li, Y Zhao, C Liu, X Chen, Y Qi, Y Jiang, C Zou, X Zhang, S Liu, X Wang, ... Clinical cancer research 17 (7), 1722-1730, 2011 | 354 | 2011 |
Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation PM Grimley, F Dong, H Rui Cytokine & growth factor reviews 10 (2), 131-157, 1999 | 295 | 1999 |
Signal transducer and activator of transcription-5 activation and breast cancer prognosis MT Nevalainen, J Xie, J Torhorst, L Bubendorf, P Haas, J Kononen, ... Journal of Clinical Oncology 22 (11), 2053-2060, 2004 | 269 | 2004 |
Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells AS Sultan, J Xie, MJ LeBaron, EL Ealley, MT Nevalainen, H Rui Oncogene 24 (5), 746-760, 2005 | 230 | 2005 |
Inactivation of interferon receptor promotes the establishment of immune privileged tumor microenvironment KV Katlinski, J Gui, YV Katlinskaya, A Ortiz, R Chakraborty, ... Cancer cell 31 (2), 194-207, 2017 | 222 | 2017 |
Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580 L DaSilva, H Rui, RA Erwin, OMZ Howard, RA Kirken, MG Malabarba, ... Molecular and cellular endocrinology 117 (2), 131-140, 1996 | 219 | 1996 |
RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response A Ertel, JL Dean, H Rui, C Liu, A Witkiewicz, KE Knudsen, ES Knudsen Cell cycle 9 (20), 4153-4163, 2010 | 198 | 2010 |
Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice KU Wagner, A Krempler, AA Triplett, Y Qi, NM George, J Zhu, H Rui Molecular and cellular biology 24 (12), 5510-5520, 2004 | 189 | 2004 |
Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells H Yamashita, J Xu, RA Erwin, WL Farrar, RA Kirken, H Rui Journal of Biological Chemistry 273 (46), 30218-30224, 1998 | 186 | 1998 |
Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors L DaSilva, OM Howard, H Rui, RA Kirken, WL Farrar Journal of Biological Chemistry 269 (28), 18267-18270, 1994 | 184 | 1994 |
Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression KU Wagner, H Rui Journal of mammary gland biology and neoplasia 13, 93-103, 2008 | 179 | 2008 |
Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells TJ Ahonen, J Xie, MJ LeBaron, J Zhu, M Nurmi, K Alanen, H Rui, ... Journal of Biological Chemistry 278 (29), 27287-27292, 2003 | 174 | 2003 |
JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization H Rui, JJ Lebrun, RA Kirken, PA Kelly, WL Farrar Endocrinology 135 (4), 1299-1306, 1994 | 174 | 1994 |
Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation. H Rui, JY Djeu, GA Evans, PA Kelly, WL Farrar Journal of Biological Chemistry 267 (33), 24076-24081, 1992 | 164 | 1992 |
Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer AK Witkiewicz, A Dasgupta, K Nguyen, C Liu, AJ Kovatich, GF Schwartz, ... Cancer biology & therapy 8 (11), 1071-1079, 2009 | 156 | 2009 |
Effects of growth hormone and prolactin immune development and function WJ Murphy, H Rui, DL Longo Life sciences 57 (1), 1-14, 1995 | 148 | 1995 |
Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless RA Erwin, RA Kirken, MG Malabarba, WL Farrar, H Rui Endocrinology 136 (8), 3512-3518, 1995 | 137 | 1995 |
An interferon-driven oxysterol-based defense against tumor-derived extracellular vesicles A Ortiz, J Gui, F Zahedi, P Yu, C Cho, S Bhattacharya, CJ Carbone, Q Yu, ... Cancer cell 35 (1), 33-45. e6, 2019 | 135 | 2019 |
CCR5 governs DNA damage repair and breast cancer stem cell expansion X Jiao, MA Velasco-Velazquez, M Wang, Z Li, H Rui, AR Peck, JE Korkola, ... Cancer research 78 (7), 1657-1671, 2018 | 128 | 2018 |